[PDF][PDF] Deubiquitination and stabilization of PD-L1 by CSN5

SO Lim, CW Li, W Xia, JH Cha, LC Chan, Y Wu… - Cancer cell, 2016 - cell.com
SO Lim, CW Li, W Xia, JH Cha, LC Chan, Y Wu, SS Chang, WC Lin, JM Hsu, YH Hsu, T Kim
Cancer cell, 2016cell.com
Pro-inflammatory cytokines produced in the tumor microenvironment lead to eradication of
anti-tumor immunity and enhanced tumor cell survival. In the current study, we identified
tumor necrosis factor alpha (TNF-α) as a major factor triggering cancer cell
immunosuppression against T cell surveillance via stabilization of programmed cell death-
ligand 1 (PD-L1). We demonstrated that COP9 signalosome 5 (CSN5), induced by NF-κB
p65, is required for TNF-α-mediated PD-L1 stabilization in cancer cells. CSN5 inhibits the …
Summary
Pro-inflammatory cytokines produced in the tumor microenvironment lead to eradication of anti-tumor immunity and enhanced tumor cell survival. In the current study, we identified tumor necrosis factor alpha (TNF-α) as a major factor triggering cancer cell immunosuppression against T cell surveillance via stabilization of programmed cell death-ligand 1 (PD-L1). We demonstrated that COP9 signalosome 5 (CSN5), induced by NF-κB p65, is required for TNF-α-mediated PD-L1 stabilization in cancer cells. CSN5 inhibits the ubiquitination and degradation of PD-L1. Inhibition of CSN5 by curcumin diminished cancer cell PD-L1 expression and sensitized cancer cells to anti-CTLA4 therapy.
cell.com